| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.5B | $9.6B | $8.2B | $6.0B | $6.0B | $6.2B | $5.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.9B | $2.6B | $2.7B | $2.0B | $1.9B | $1.4B | $1.9B | $1.9B |
| EPS (Basic) | $17.10 | $14.71 | $15.85 | $11.59 | $13.81 | $9.94 | $13.76 | $12.75 |
| EPS (Diluted) | $17.00 | $14.64 | $15.79 | $11.53 | $13.80 | $9.94 | $13.75 | $12.74 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $213.5B | $208.1B | $208.3B | $200.7B | $155.1B | $142.6B | $119.9B | $120.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $184.3B | $179.1B | $181.3B | $175.4B | $137.2B | $126.4B | $104.2B | $104.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $29.2B | $29.0B | $27.0B | $25.3B | $17.9B | $16.2B | $15.7B | $15.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.0B | $3.6B | $3.9B | $4.6B | $2.7B | $0.8B | $2.4B | $2.1B |
| Investing Cash Flow | $-6.8B | $-0.6B | $-7.9B | $16.6B | $-13.6B | $-22.0B | $0.7B | $-1.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $1.8B | $-2.9B | $4.2B | $-21.0B | $10.7B | $21.3B | $-3.3B | $-0.5B |